Patient-forward: Aspiring to make a difference in cancer
Novocure is a global oncology company dedicated to extending survival in some of the most aggressive forms of cancer. Novocure achieves this through the development and commercialization of its innovative therapy, Tumor Treating Fields (TTFields). Approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for adult patients with malignant pleural mesothelioma, Novocure's commercialized products represent a significant advancement in cancer treatment. The company's commitment to patient-forward solutions drives its ongoing pursuit of impactful therapies.
Headquartered in Root, Switzerland at Park 6, 6039 Root D4, CH-6039, with U.S. operations in Portsmouth, New Hampshire, and Chesterbrook, Pennsylvania, Novocure maintains a global presence with additional offices in Canada, Germany, Japan, Poland, and Israel. Novocure's extensive research and development efforts include ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer, and gastric cancer. This broad clinical program underscores Novocure's dedication to expanding the application of TTFields technology to a wide range of cancers.
Novocure is committed to making a difference in the lives of cancer patients and their families. For more information about Novocure and its innovative therapies, please visit http://www.novocure.com. We invite the management team at Novocure to create a customized and exclusive company showcase and product listing on our platform.
Compare Novocure with 3 companies in Medical-Equipment-Manufacturing
| Comparison Field |
NovocureMain Company |
Day One Biopharmaceu...View Profile |
Te
Telix Pharmaceutical...View Profile |
Medneon (Acquired by...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2018 | 2015 | 2018 |
|
Company Size
|
— | 51-200 | 501-1,000 | 11-50 |
|
City
|
Root, Switzerland | Brisbane, California | North Melbourne, Victoria | Cupertino, CA |
|
Country
|
United States | Australia | United States | |
|
Skills & Keywords
Comparing with main company
|
9 Total Skills
Oncology
Tumor Treating Fields
Glioblastoma
Mesothelioma
Cancer Therapy
Medical Devices
Neuro-Oncology
Medical Device
Cancer
|
9 Total
9 Unique
Unique Skills:
Biotechnology
Childhood Cancer
Drug Development
Glioma
Hematology
MAPK
+3
|
12 Total
1 Common
11 Unique
Match
11%
Common Skills:
Cancer Therapy
Unique Skills:
Cancer Imaging
Molecular Imaging
Molecularly Targeted Radiation
Nuclear Medicine
Positron Emission Tomography
Prostate Cancer
+5
|
17 Total
17 Unique
Unique Skills:
Artificial Intelligence
Breast Cancer
Clinical Insights
Data Science
DNA
Genetic Insights
+11
|
Other organizations in the same industry
This company is also known as